Chronic lymphocytic leukaemia (CLL) cells exist in the lymph nodes, bone marrow and peripheral blood. Leukaemic cells within tissues survive and proliferate whereas in the peripheral blood they are quiescent and die readily. One of the causes for the failure of current treatments may be that signals from stromal cells, T-cells or other cells within tissues, as well as growth factors and chemokines, promote CLL cell survival. The mechanisms for increased survival within tissues are not well understood, but may provide novel targets for therapy.
Several culture systems are capable of maintaining CLL cells and driving proliferation. To supply stromal and T-cell elements, we employed mouse fibroblasts expressing human CD40 ligand (CD154) with IL-4. 1 On direct comparison, murine stromal cells have a similar capacity to human stromal cells to support of B-cell survival. 2 Short-term culture on this system is capable of reproducing some of the changes in protein expression observed in CLL cells within lymph nodes. 3 MicroRNAs (miRNA) are oligonucleotides that bind imperfectly to the 3 0 -UTR of many mRNAs. In mammalian cells binding of miRNAs to their target mRNAs can lead to a reduction in translation. MiRNA expression, measured in non-dividing CLL cells, has been used to produce a prognostic classification. 4 Direct evidence for the involvement of miRNA in CLL comes from mice bearing deletions of miR-15a and miR-16-1, which are found on a section of chromosome 13q deleted in over 50% of cases of the human leukaemia. These animals develop a disease similar to human CLL. 5 Therefore, miRNA are clinically important markers and have biological relevance in CLL but previously their expression has only been measured in freshly isolated peripheral blood cells. In order to find out changes due to CD154 we used Taqman low density microRNA arrays to compare CLL cells cultured on stromal cells alone with those cultured on stromal cells with CD154. In addition miRNA expression in freshly isolated peripheral blood cells was compared with leukaemic cells cultured on stromal cells alone to measure the effects of cell --cell contact without the effects of CD154. We chose freshly isolated peripheral blood cells because their viability was comparable to that produced by stromal cell culture whereas leukaemic cells cultured on plastic had a variable amount of spontaneous apoptosis. However, to demonstrate that time in culture did not produce major changes in miRNA expression we directly compared the two culture conditions (Supplementary Figure 1) . Principal component analysis ( Figure 1a ) showed that each sample group had separable characteristics. To identify miRNAs that are induced or repressed, expression levels were compared, by ANOVA, between the three groups This resulted in the identification of 74 miRNAs (Po0.01) that were significantly regulated (Figure 1b and Supplementary  Table 2 ). The majority (70/74) of these miRNA were upregulated on stromal cell and CD154 culture.
The 20 miRNA that were most strongly induced by stromal cell culture, that is, comparing freshly isolated peripheral blood expression with expression on stromal cell culture (Table 1a) demonstrated that profound changes occur in the CLL miRNome due to cell --cell contact with fibroblasts only. In order to validate the microarray results further patient samples were tested (n ¼ 8) (Figure 2a) . Some of the most strongly induced miRNA---miR-125b, miR-99a and let-7c-belong to a cluster on chromosome 21, Table 1 ). Patients were untreated, and all had white cell counts 490 Â 10 9 /l, with CD38o1% and mutated immunoglobulin genes. Results were normalised to the internal control RNU44. Data analysis was performed using Multiple Experiment Viewer (MeV v10.2). The microarray data has been deposited with GEO (GSE24694 and GPL11050). suggesting increased transcription from the whole locus is driven by stromal cell contacts. Similarly, CD154 coordinately regulated miR-212 and miR-132, which are on a locus at chromosome 17p13.3. MiR-221, which has been implicated in the regulation of p27 and cell cycle entry in CLL 6 is induced by over 100-fold. One reason for the very large inductions observed is that these miRNA are detectable at extremely low levels in freshly isolated CLL cells indicating that the miRNome of CLL cells in lymph nodes or bone marrow is very different from that of peripheral blood cells.
The overall level of induction due to CD154 was less than that for stromal cell culture, in part, because of higher basal expression (Table 1b) . For example, miR-155, which is required for normal B-cell development and whose expression is associated with karyotpic abnormalities in CLL, is known to be highly expressed in leukaemic cells from peripheral blood and there is a further increase in lymph nodes. 7 In confirmation of this we found high basal expression of miR-155 and induction on CD154 culture, but not by stromal cells alone (Figure 2a ). CD154, therefore, appears to have an important role in miR-155 regulation. MiR-193b is also strongly induced by CD154 culture. It is highly expressed in multiple myeloma, 8 but its targets during B-cell differentiation are unknown. A B-cell function has not been assigned to miR-183 but it was implicated in cell migration in breast cancer, 9 and regulation of NF-kB and b-catenin signalling. 10 MiR-212 and miR-132 have an essential role in regulating epithelial --stromal interactions in the developing mammary gland 11 but, again, a B-cell function has not been reported.
MiR-17-92 is a cluster of six miRNA processed from a common primary transcript. The cluster has an important role in the pathogenesis of human cancers. Transgenic expression in mice leads to a lymphoproliferative disorder, and the animals bearing homologous disruption of the locus demonstrate defective B-cell development. Constitutive expression of miR-17-92 cooperates with the c-MYC oncogene in a mouse model of B-cell lymphomas and c-MYC itself directly activates miR-17-92, suggesting that this cluster of miRNA may mediate some of the oncogenic effects of c-MYC possibly by suppressing apoptosis. 12 The individual cluster members miR-19a and miR-19b are sufficient to produce the effects of the entire cluster in cell line and animal models of lymphoma. 12 Four out of the six members of the miR-17-92 cluster (miR-17, miR-20a, miR-18a and miR-19b) are significantly regulated by CD154 (Figure 1b ). Other members of the family are induced but outside the significance level of the study (miR-19a and miR-92a (ANOVA, Po0.02)). For all members of the miR-17-92 cluster, apart from miR-92a, stromal cell culture produced an increase in miRNA expression, which was increased further by CD154 (Figure 2a) . The most highly expressed members of the cluster following CD154 culture are miR-17 and miR-19b, with miR-20a being expressed at about half, and miR-18a, miR-19a and miR-92a at about one tenth of this level. MiR-17-92 has two paralog clusters: miR-106a-363 and miR-106b-25. Of the six members of the miR-106a-363 cluster only miR-106a is significantly altered in the culture conditions (P ¼ 3.1 Â 10 À4 ) but all three miR-106b-25 are significantly induced (miR-106b, P ¼ 1.1 Â 10 À4 ; miR-93, P ¼ 2.5 Â 10
À4
; miR-25, P ¼ 3.2 Â 10 À4 ) (Figure 2a) . The miR-106b-25 cluster cooperates with miR-17-92 in the embryonic development 13 but its role in mature animals has not been investigated.
c-MYC drives the expression of miR-9 14 and the miR-17-92 cluster. 15 c-MYC was not detectable in freshly isolated peripheral blood CLL cells but was induced by stromal cell culture with a further increase due to CD154 culture (Figure 1c ). MiR-9 and miR-17-92 show a stepwise increase in expression compatible with a role for c-MYC. This pattern of expression is also observed for miR106a, the miR-106b/93/25 cluster and miR-212/132 for which a role of c-MYC has not been defined. The stepwise increase in miRNA expression appears to be specific because it is not observed for miR-155, which requires CD154 for induction, or the miR-125b/let-7c/miR-99a cluster, for which stromal cell contact appears sufficient.
In order to define possible associations with some of the most important indices of clinical outcome, expression levels of five of the most highly expressed miRNAs were measured in a further group of samples (Figure 2b ). There was a significant (Po0.05, Mann --Whitney U-test) association between low miRNA expression and unmutated immunoglobulin genes for miR-17, miR-19b, miR-20a and miR-125b. Responses to CD40 signalling have recently been shown to discriminate between different clinical outcomes, 16 and it is possible that differences in induced miRNA expression contribute to the observed differences in transcription factors and surface markers. In our cases there was no association between miRNA expression and either CD38 or chromosomal abnormalities. 
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Abbreviation: CLL, chronic lymphocytic leukaemia. The miRNA clusters (miR-125b/let-7c/miR-99a and miR-17/miR-20a/miR-18a/ miR-19b) are in bold. miR-9 occurs in both groups (italics). The adjusted P-value and fold change are presented.
Letters to the Editor
This report shows major changes in the miRNome due to culture conditions, which produced upregulation of miRNA that are not detectable in peripheral blood leukaemic cells. This suggests that CLL cells in tissues (lymph nodes or bone marrow) express very different miRNA to peripheral blood cells implying that the miRNome of CLL cells in tissues will be important to consider in future prognostic and biological studies. Secondly, we found induction of certain miRNA clusters. Not only were members of the oncomir miR-17-92 cluster upregulated, but the miR-125b/miR-99a/let-7c, miR-106b/miR-93/miR-25 and miR-212/ miR-132 clusters are also coordinately regulated either by stromal cell contact alone (in the case of the miR-125b cluster) or by CD154. Therefore, the targets of stromal cell or CD154 stimulation are miRNA clusters at specific chromosomal loci and not just individual miRNA. As well as coordinate expression there may also be coordinate functions of these clusters in survival or proliferation of CLL cells in tissues. It is interesting that recent work has shown constitutive expression of miR-125b to be sufficient for the generation of acute leukaemias in a mouse model 17 and that this miRNA is enriched in normal germinal centre B-cells, 18 suggesting that it confers a proliferative advantage. However, miR125b has not previously been implicated in low-grade lymphoproliferative disease.
We have shown that CD40 stimulation produces changes in miRNA expression in CLL, and we speculate that this contributes to the survival and proliferation of CLL cells in lymph nodes.
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The authors declare no conflict of interest. however, the molecular mechanisms underlying this phenomenon remain unknown. In contrast to most epithelial cancers, MM lacks mutations in critical components of this pathway, suggesting that deregulated post-translational mechanisms contribute to the aberrant expression of WNT pathway proteins. 1, 5 We and others have documented the overexpression of the central WNT signaling molecule, b-catenin, in a majority of MM PCs as compared with normal PCs.
1 --3,6,7 Post-translational regulation of b-catenin is typically mediated through phosphorylation events that tag the protein for ubiquitination and degradation through the 26S proteasome. In most cellular contexts, the ubiquitin --proteasome system (UPS) is sufficient to handle normal protein synthesis, misfolding and turnover; 8 however, exceeding the capacity of the UPS causes polypeptides to accumulate in cytosolic aggregates near the perinuclear microtubule organizing center. Continued stress on the UPS causes additional protein aggregates to amass, forming a dense structural assembly termed the aggresome. 9 Aggresomes recruit additional protein catabolic machinery to aid in the unfolding of compacted proteins for proteasomal or autophagosomal/lysosomal removal. 10 Thus, aggresome formation provides a reserve protein processing unit to the proteasome to eliminate unwanted proteins.
To determine the cellular localization of b-catenin, we first performed immunofluorescence (IFC) and immunohistochemical (IHC) analyses in MM cells using an antibody against this key signaling molecule. Consistent with prior reports, most cell lines showed diffused distribution of b-catenin within the cytoplasm and punctuated signals within the nucleus (Figure 1a) . 1, 2, 6 However, strong b-catenin signal was also observed in distinct perinuclear aggregates from a subpopulation of cultured MM cell lines (Figure 1a) . In order to delineate the identity of these structures, we performed double IFC analysis that demonstrated colocalization of the b-catenin signal with known aggresomal markers such as HDAC6, ubiquitin, vimentin and g-tubulin (Figure 1b and data not shown) . 9, 11 However, the expression of Golgi body markers Giantin and 58 K as well as ER marker Calnexin was distinctly different from that of the aggresome (Figures 1c and d) . Scanning electron microscopy (SEM) further confirmed these findings (Figure 1e and Supplementary Figure 1) .
We suspected that b-catenin could be used as a marker of aggresomes to identify malignant PCs in patient samples. We therefore evaluated the staining pattern in MM paraffin-embedded biopsies using two different antibodies that recognize
